Skip to Main Content
Center for Cancer ResearchCCR Home | About CCR | CCR Intranet

Headlines

Headline Title

Neurofibromatosis

Clinical Trials

Neurofibromatosis Protocol Information

All Clinical Trials Information

Protocol Number Title Study Status PI Website Section
Phase 1
11C0161 A Phase 1 Study of the Mitogen Activated Protein Kinase Kinase (MEK) 1 Inhibitor AZD6244 Hydrogen Sulfate (Selumetinib Sulfate) in Children with Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN) Currently Accruing Widemann, Brigitte
Link Pharmacology and Experimental Therapeutics
Neurofibromatosis
Phase 2
08C0130 A Phase II Trial of Peginterferon alfa-2b (Pegintron) for Neurofibromatosis Type 1 Related Unresectable, Symptomatic or Life-Threatening Plexiform Neurofibromas  Currently Accruing Widemann, Brigitte
Link Neurofibromatosis
12C0058 A Phase II Study of Everolimus (RAD001) for Children with Neurofibromatosis Type-1 and Chemotherapy-Refractory Radiographic Progressive Low-Grade Gliomas Currently Accruing Warren, Kathy
Link Neuro-Oncology
Neurofibromatosis
12C0148 SARC016: Phase II Study of the mTOR Inhibitor Everolimus in Combination With Bevacizumab in Patients With Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors Currently Accruing Widemann, Brigitte
Link Pharmacology and Experimental Therapeutics
Neurofibromatosis
Natural History
08C0079 Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults with Neurofibromatosis Type 1 Currently Accruing Widemann, Brigitte
Link Neurofibromatosis
Other
12C0155 Acceptance and Commitment Therapy for Adolescents and Adults With Neurofibromatosis Type 1 and Chronic Pain: A Pilot Study Currently Accruing Peron, Staci
Link Psychosocial
Neurofibromatosis
12C0160 Validation of the English Version of the Pain Interference Index and the Pain Rating Scale in Children, Adolescents, and Young Adults With Chronic Illness and Their Parents Currently Accruing Peron, Staci
Link Psychosocial
Neurofibromatosis
Solid Tumors
Hematologic Diseases
Dashed Line

return to the top

This Page Last Reviewed on April 28, 2011

About CCR | Clinical Trials | Research | Employment | Initiatives | News | Events | Site Privacy Policy | Accessibility

A Service of the National Cancer Institute

Department of Health and Human Services National Institutes of Health (NIH) USA Gov